Medical Triage in a Time of Scarce Resources. (XPHI-COVID-2)

September 8, 2022 updated by: University Hospital, Caen

Medical Triage in a Time of Scarce Resources: a Randomized Controlled Study.

The XPHI-COVID-2 randomized study aims to investigate the moral choices in a context of scarce resources.

The participants are asked to complete the questionnaire of the Oxford Utilitarianism Scale and are exposed to medical triage dilemmas.

Participants are randomized between a group with reading of ethical guidelines and a group without reading of ethical guidelines, before they are asked to complete the questionnaire and being exposed to triage dilemmas.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

It is hypothesized that recalling ethical values before resolving dilemmas could modify the ability to adopt a utilitarian approach in resolving ethical dilemmas.

To verify this hypothesis, the score on the Impartial Harm subscale of the Oxford Utilitarianism Scale (IH-OUS) will be compared between a group with reading of ethical guidelines and a group without reading of ethical guidelines, before they are asked to complete the questionnaire and being exposed to triage dilemmas.

Number of subjects needed for the phase of study evaluating intensivists, anesthesiologists and emergency physicians : 580 - based on preliminary data, assuming 70% complete response rate of the survey and a standard deviation of 5

Secondary outcomes will be considered :

  • Beneficence Harm subscale of the Oxford Utilitarianism Scale (IB-OUS)
  • Values prioritized to resolve ethical dilemmas : impartial of benefits, prioritization of the young age, saving life years, saving most lives, equality of treatment, prioritization of the worst off, loyalty duty, principle of non-discrimination, prospective and retrospective instrumental value.

First phase of the study will aim to include first-line caregivers : intensivists, anesthesiologists, emergency physicians.

Other phases of the study will aim to include health care professionals from other categories and non health care professionals.

Subgroup analyses are planned :

  • Analysis according to the characteristics of the participant: gender, geographic location, diploma and type of exercise, category of institution to which the participant is attached.
  • Analysis according to the degree of knowledge in ethics, the degree of familiarity with ethical recommendations, the degree of familiarity with moral philosophy, the degree of religiosity, whether the participants declare to have taken knowledge or not of recommendations concerning medical triage in a situation of scarce resources.

It is also planned to carry out ancillary studies in parallel with the realization of the study presented here:

  • A study including non-physician participants aiming to identify the differences between non-physicians and physicians in terms of ethical values mobilized in medical triage.
  • A study including medical students aiming to identify an association between propensity to make utilitarian and choices of the medical specialty.
  • A study focused on the Oxford Utilitarianism Scale, integrating the results of the pilot study and the confirmatory study, aiming to identify predictors of responses to the dilemmas proposed within the scale.
  • A study evaluating the association between delay in ethical dilemmas resolution and utilitarian choices.

Study Type

Interventional

Enrollment (Anticipated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Calvados
      • Caen, Calvados, France, 14000
        • Recruiting
        • CAEN University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Caregivers
  • Noncaregivers from general population

Exclusion Criteria:

  • Withdrawal of agreement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The participants have to read ethical guidelines before they are asked to complete the questionnaire of the Oxford Utilitarianism Scale and exposed to medical triage dilemmas.
Reading of ethical guidelines.
No Intervention: No intervention
The participants do not have to read ethical guidelines before they are asked to complete the questionnaire of the Oxford Utilitarianism Scale and exposed to medical triage dilemmas.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IH-OUS score
Time Frame: At the end of the inclusion period

Score on the Impartial Harm subscale of the Oxford Utilitarianism Scale (IH-OUS) : minimum value is 4 points and maximum value is 28 points.

The higher the value is, the more the participant's choices endorse the principle of causing harm to bring the greater good.

At the end of the inclusion period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Utilitarian score
Time Frame: At the end of the inclusion period
One point is given for each choice consistent with utilitarian principles when solving triage dilemmas, scaling this score from 0 to 14.
At the end of the inclusion period
IB-OUS score
Time Frame: At the end of the inclusion period

Score on the Instrumental Beneficence subscale of the Oxford Utilitarianism Scale (IB-OUS) : minimum value is 5 points and maximum value is 35 points.

The higher the value is, the more the participant's choices endorse the impartial maximization of the greater good, even at the cost of personal self-sacrifice.

At the end of the inclusion period
Oxford utilitarianism scale
Time Frame: At the end of the inclusion period

Bi-dimensional scale of utilitarian thinking associating the impartial harm and the beneficence subscale. The minimum value is 9 points and the maximum value is 63 points.

This scale aims to assess the utilitarian tendencies in people who are not philosophy professionals.

At the end of the inclusion period
Impartial of benefits
Time Frame: At the end of the inclusion period

Principle of impartial assignment of resources used in resolving ethical dilemmas.

The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.

At the end of the inclusion period
Prioritization of the young age
Time Frame: At the end of the inclusion period
Propensity to prioritize the youngest person in ethical dilemmas. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
At the end of the inclusion period
Saving life years
Time Frame: At the end of the inclusion period
Propensity to save the most life years in resolving ethical dilemmas. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
At the end of the inclusion period
Saving most lives
Time Frame: At the end of the inclusion period
Propensity to save most lives in resolving ethical dilemmas. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
At the end of the inclusion period
Equality of treatment
Time Frame: At the end of the inclusion period
Propensity to treat people equally in ethical dilemmas. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
At the end of the inclusion period
Prioritization of the worst off
Time Frame: At the end of the inclusion period
Propensity to prioritize the worst off in ethical dilemmas. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
At the end of the inclusion period
Duty of loyalty
Time Frame: At the end of the inclusion period
Propensity of the caregiver to feel obliged vis-a-vis the patient The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
At the end of the inclusion period
Principle of non-discrimination (based on age, disability, socio-economic characteristics, gender, etc.)
Time Frame: At the end of the inclusion period

The non-discrimination principle requires the equal treatment of an individual or group irrespective of their particular characteristics.

The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.

At the end of the inclusion period
Prospective instrumental value
Time Frame: At the end of the inclusion period

Propensity to promote and reward prospective instrumental value, based on future facts.

The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.

At the end of the inclusion period
Retrospective instrumental value
Time Frame: At the end of the inclusion period

Propensity to promote and reward retrospective instrumental value, based on past facts.

The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.

At the end of the inclusion period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Clément GAKUBA, MD PhD, University Hospital, Caen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Anticipated)

October 1, 2022

Study Completion (Anticipated)

November 1, 2022

Study Registration Dates

First Submitted

July 23, 2021

First Submitted That Met QC Criteria

July 28, 2021

First Posted (Actual)

July 29, 2021

Study Record Updates

Last Update Posted (Actual)

September 13, 2022

Last Update Submitted That Met QC Criteria

September 8, 2022

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 1475 (CSL Behring)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Survey

3
Subscribe